Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009;9 Suppl 3(Suppl 3):S205-10.
doi: 10.3816/CLM.2009.s.013.

Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia

Teresa Palomero  1 , Adolfo Ferrando
Affiliations
Review

Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia

Teresa Palomero et al. Clin Lymphoma Myeloma. 2009.

Abstract

The recent identification of activating mutations in NOTCH1 in the majority of T-cell acute lymphoblastic leukemias (T-ALLs) has brought major interest toward targeting the NOTCH signaling pathway in this disease. Small-molecule gamma-secretase inhibitors (GSIs), which block a critical proteolytic step required for NOTCH1 activation, can effectively block the activity of NOTCH1 mutant alleles. However, the clinical development of GSIs has been hampered by their low cytotoxicity against human T-ALL and the development of significant gastrointestinal toxicity derived from the inhibition of NOTCH signaling in the gut. Improved understanding of the oncogenic mechanisms of NOTCH1 and the effects of NOTCH inhibition in leukemic cells and the intestinal epithelium are required for the design of effective anti-NOTCH1 therapies in T-ALL.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Page

Research funding from Merck (A.F) for preclinical testing of gamma-secretase inhibitors in T-ALL. No other conflicts of interest. ”

Figures

FIGURE 1
FIGURE 1. THE NOTCH1 SIGNALING PATHWAY
The NOTCH1 receptor is activated upon interaction with Delta-like and Jagged ligands expressed the surface of a neighbor cell. This ligand-receptor interaction results in a conformational change in the LNR repeats of NOTCH1 and the dissociation of the two subunits of the HD domain, which is followed by cleavage of the receptor, first by an ADAM metalloprotease (S2 cleavage) and subsequently by the γ-secretase complex (S3 cleavage). This latter proteolytic processing releases the intracellular domains of NOTCH1 (ICN1) from the membrane. ICN1 interacts with DNA via the CSL DNA binding protein and recruits the MAML1 coactivator to activate the expression of NOTCH1 target genes.
FIGURE 2
FIGURE 2. STRUCTURE AND MECHANISM OF ACTION OF ONCOGENIC FORMS OF NOTCH1
NOTCH1 mutations located in the HD domain of the receptor increase ICN1 levels by inducing ligand independent NOTCH1 signaling. Truncations of the PEST domain of NOTCH1 (ΔPEST mutations) result in accumulation of ICN1 in the nucleus by impairing the degradation of activated NOTCH1.
FIGURE 3
FIGURE 3. PREVALENCE OF ACTIVATING MUTATIONS IN NOTCH1 IN T-ALL
HD and ΔPEST mutations account for the majority of activating mutations in NOTCH1 in T-ALL. An additional 1% of patients harbor translocations involving NOTCH1 and the TCR loci. NOTCH1 JME mutations related to HD mutant alleles are found in 3% of all T-ALLs. Finally about 15% of T-ALL cases harbor deletions or mutations in FBXW7, which are functionally related to NOTCH1 ΔPEST mutant alleles.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ferrando AA, Look AT. Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. Semin Hematol. 2000;37:381–395. - PubMed
    1. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med. 2004;350:1535–1548. - PubMed
    1. Pui C. Childhood leukemiased. Cambridge: Cambridge University Press; 1999.
    1. Silverman LB, Sallan SE. Acute lymphoblastic leukemia. In: Nathan DG, Ginsburg D, Look AT, editors. Hematology of infancy and childhood. Philadelphia: W.B. Saunders; 2000. pp. 575–592.
    1. Chessells JM, Bailey C, Richards SM. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia. Lancet. 1995;345:143–148. - PubMed

Publication types

MeSH terms